The global digital PCR market size was estimated to be USD 0.67398 Billion in 2023 and is expected to reach at USD 1.8363 Billion by 2033 with a CAGR of 9.54% during the forecast period 2023-2033. Growing prevalence of cancers such as lung cancer, blood cancer, & brain tumor, increasing demand for molecular diagnosis of cancer, rising advantages of digital PCR over traditional PCR technology, surge in healthcare expenditure, growing demand for accurate molecular diagnosis of diseases, increasing advancement in digital PCR technology, rising research & development activities or advancement in PCR technology, and surge in number of digital & innovative product launch are some of the key factors boosting the market growth.
Surge in number of digital & innovative product launch is predicted to boost the market growth during the forecast period. For instance, in January 2022, QIAGEN N.V. has unveiled new expansions to the applications available for QIAcuity, its ultrasensitive digital PCR (dPCR) platform. This platform utilizes nanoplates, enabling sample processing in just two hours, a significant improvement compared to other systems that typically require five hours.
By Product, Digital PCR systems was the highest revenue-grossing segment in the global digital PCR market in 2022 owing to the growing demand for molecular diagnostics in personalized medicine, rising technological advancements, and increasing launch of new products. For instance, in November 2022, Shenzhen New Industries Biomedical Engineering CO. Ltd. introduced the Molecision S6 digital PCR system, a new addition to the Snibe Molecular portfolio, during MEDICA 2022. This automated and integrated system offers a complete platform solution for research and in vitro diagnostics. Additionally, Consumables & reagents is predicted to grow at fastest CAGR during the forecast period owing to the increasing demand for early diagnosis and rise in manufacturing of consumable & reagents for digital PCR by key market players.
By Technology, Droplet digital PCR (ddPCR) was the highest revenue-grossing segment in the global digital PCR market in 2022 owing to the rising prevalence of infectious diseases, growing focus on development & commercialization of ddPCR for infectious disease diagnosis, and surge in launch of technologically advanced systems. For instance, in April 2023, Bio-Rad Laboratories, Inc. has unveiled the QX600 Droplet Digital PCR System, which shares the same droplet generation and processing protocols as the QX200 System. The QX600 System also allows for effortless adoption of its enhanced multiplexing capabilities. Additionally, Chip based digital PCR is predicted to grow at fastest CAGR during the forecast period owing to the increasing advancement in chip based digital PCR technology and growing launch of advanced products.
By Application, Genetic disorders was the highest revenue-grossing segment in the global digital PCR market in 2022 owing to the surge in prevalence of genetic disorders, growing adoption of advanced devices for the identification of gene alterations, and increasing investment by government & private bodies. For instance, in November 2021, Stilla Technologies has disclosed a new project with a USD 31.3 million investment from the European Investment Bank. The primary aim of the project is to expedite the advancement of next-generation genetic tests through the provision of an innovative and adaptable solution. Additionally, Oncology is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of cancer, increasing research & development activities, and rising demand for digital devices.
By End-User, Academic & Research Organizations was the highest revenue-grossing segment in the global digital PCR market in 2022 owing to the rising demand for these devices for research studies in various fields such as genetic diseases, oncology, & others and growing launch of advanced devices. For instance, in February 2023, The Applied Biosystems QuantStudio Absolute Q AutoRun dPCR Suite is a cutting-edge research tool for digital PCR that was released by Thermo Fisher Scientific Inc. Additionally, Clinical diagnostic laboratories is predicted to grow at fastest CAGR during the forecast period owing to the surge in prevalence of cancer & infectious diseases, growing number of clinical research centers, surge in clinical trial procedures, surge in demand for digital devices for diseases diagnosis.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in prevalence of cancer, increasing development of digital PCR devices, rising healthcare infrastructure, growing adoption of technologically advanced diagnostics, and surge in launch of new products. For instance, in October 2022, Standard BioTools Inc. has unveiled the X9 Real-Time PCR Systems, a cutting-edge high-capacity genomics instrument known for its exceptional efficiency. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing number of hospitals, rising prevalence of cancer, increasing research & development activities, and surge in launch of innovative & technologically advanced products. For instance, in August 2022, A new digital polymerase chain reaction (PCR) technology from Roche called the Digital LightCyclerR technology has been unveiled. This advanced technology enables the detection of diseases and is specifically designed to precisely quantify minute quantities of particular DNA and RNA targets that are usually undetectable through traditional PCR methods.
Surge in number of digital & innovative product launch is predicted to boost the market growth during the forecast period. For instance, in January 2022, QIAGEN N.V. has unveiled new expansions to the applications available for QIAcuity, its ultrasensitive digital PCR (dPCR) platform. This platform utilizes nanoplates, enabling sample processing in just two hours, a significant improvement compared to other systems that typically require five hours.
By Product, Digital PCR systems was the highest revenue-grossing segment in the global digital PCR market in 2022 owing to the growing demand for molecular diagnostics in personalized medicine, rising technological advancements, and increasing launch of new products. For instance, in November 2022, Shenzhen New Industries Biomedical Engineering CO. Ltd. introduced the Molecision S6 digital PCR system, a new addition to the Snibe Molecular portfolio, during MEDICA 2022. This automated and integrated system offers a complete platform solution for research and in vitro diagnostics. Additionally, Consumables & reagents is predicted to grow at fastest CAGR during the forecast period owing to the increasing demand for early diagnosis and rise in manufacturing of consumable & reagents for digital PCR by key market players.
By Technology, Droplet digital PCR (ddPCR) was the highest revenue-grossing segment in the global digital PCR market in 2022 owing to the rising prevalence of infectious diseases, growing focus on development & commercialization of ddPCR for infectious disease diagnosis, and surge in launch of technologically advanced systems. For instance, in April 2023, Bio-Rad Laboratories, Inc. has unveiled the QX600 Droplet Digital PCR System, which shares the same droplet generation and processing protocols as the QX200 System. The QX600 System also allows for effortless adoption of its enhanced multiplexing capabilities. Additionally, Chip based digital PCR is predicted to grow at fastest CAGR during the forecast period owing to the increasing advancement in chip based digital PCR technology and growing launch of advanced products.
By Application, Genetic disorders was the highest revenue-grossing segment in the global digital PCR market in 2022 owing to the surge in prevalence of genetic disorders, growing adoption of advanced devices for the identification of gene alterations, and increasing investment by government & private bodies. For instance, in November 2021, Stilla Technologies has disclosed a new project with a USD 31.3 million investment from the European Investment Bank. The primary aim of the project is to expedite the advancement of next-generation genetic tests through the provision of an innovative and adaptable solution. Additionally, Oncology is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of cancer, increasing research & development activities, and rising demand for digital devices.
By End-User, Academic & Research Organizations was the highest revenue-grossing segment in the global digital PCR market in 2022 owing to the rising demand for these devices for research studies in various fields such as genetic diseases, oncology, & others and growing launch of advanced devices. For instance, in February 2023, The Applied Biosystems QuantStudio Absolute Q AutoRun dPCR Suite is a cutting-edge research tool for digital PCR that was released by Thermo Fisher Scientific Inc. Additionally, Clinical diagnostic laboratories is predicted to grow at fastest CAGR during the forecast period owing to the surge in prevalence of cancer & infectious diseases, growing number of clinical research centers, surge in clinical trial procedures, surge in demand for digital devices for diseases diagnosis.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in prevalence of cancer, increasing development of digital PCR devices, rising healthcare infrastructure, growing adoption of technologically advanced diagnostics, and surge in launch of new products. For instance, in October 2022, Standard BioTools Inc. has unveiled the X9 Real-Time PCR Systems, a cutting-edge high-capacity genomics instrument known for its exceptional efficiency. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing number of hospitals, rising prevalence of cancer, increasing research & development activities, and surge in launch of innovative & technologically advanced products. For instance, in August 2022, A new digital polymerase chain reaction (PCR) technology from Roche called the Digital LightCyclerR technology has been unveiled. This advanced technology enables the detection of diseases and is specifically designed to precisely quantify minute quantities of particular DNA and RNA targets that are usually undetectable through traditional PCR methods.
Segmentation: Digital PCR Market Report 2022 - 2033
Digital PCR Market Analysis & Forecast by Product 2022 - 2033 (Revenue USD Mn)
- Digital PCR Systems
- Consumables & Reagents
- Software & Services
Digital PCR Market Analysis & Forecast by Technology 2022 - 2033 (Revenue USD Mn)
- Chip Based Digital PCR
- Droplet Digital PCR (Ddpcr)
- Beaming Digital PCR
Digital PCR Market Analysis & Forecast by Application 2022 - 2033 (Revenue USD Mn)
- Genetic Disorders
- Infectious Diseases
- Oncology
- Others
Digital PCR Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Mn)
- Clinical Diagnostic Laboratories
- Hospitals & Clinics
- Pharmaceuticals & Biotechnology Industries
- Academic & Research Organizations
Digital PCR Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Mn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Digital PCR Market: Product Estimates & Trend Analysis
8. Digital PCR Market: Technology Estimates & Trend Analysis
9. Digital PCR Market: Application Estimates & Trend Analysis
10. Digital PCR Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Digital PCR Market
13. Europe Global Digital PCR Market
14. Asia Pacific Global Digital PCR Market
15. Latin America Global Digital PCR Market
16. MEA Global Digital PCR Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Fluidigm Corporation
- QIAGEN N.V
- Bio-Rad Laboratories Inc.
- Avance Biosciences
- Precigenome LLC
- Sysmex Corporation
- Merck KGAA
- jn medsys
- STILLA TECHNOLOGIES
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 0.67 Billion |
| Forecasted Market Value ( USD | $ 1.84 Billion |
| Compound Annual Growth Rate | 9.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
